Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Cystic Fibrosis Therapeutics Market

Cystic Fibrosis Therapeutics Market Trends

  • Report ID: GMI5118
  • Published Date: Sep 2021
  • Report Format: PDF

Cystic Fibrosis Therapeutics Market Trends

Growing awareness in the emerging countries regarding the oral drug treatments such as pancreatic enzyme supplements and CFTR modulators for cystic fibrosis and their cost affordability is a major factor that is expected to foster the market progression. Cystic fibrosis is an inherited disorder that damage lungs and body organ. Numerous healthcare organizations, and medical institutes spread awareness about the treatment of cystic fibrosis to enhance public health. The Cystic Fibrosis Foundation, spread awareness about cystic fibrosis through social media, sharing personal stories about diagnosis, various treatments, and many more.
 

Increasing awareness among patient population and healthcare professionals about the availability of advanced medications in the market and their benefits over the present drug product portfolio is poised to boost the market over the forecast period. Furthermore, rising prevalence of cystic fibrosis disease in developed countries such the U.S., is increasing demand and usage of technologically advanced medications for cystic fibrosis will augment the industry growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global cystic fibrosis therapeutics market size was over USD 8.5 billion during 2020 and is anticipated to register about 16.1% CAGR over 2021-2027.

Medications held nearly USD 6.1 billion share of global cystic fibrosis therapeutics industry in 2020 with increasing demand for mucus thinner, bronchodilators, bronchodilators and other products.

Hospitals are expected to account for almost 49% of cystic fibrosis therapeutics consumption by 2027, with the demand for precise diagnosis and treatments by experienced medical professionals.

North America held around 76% of cystic fibrosis therapeutics industry share during 2020 and the share will expand with high prevalence of the disorder and wider availability of treatment options in the region.

Major companies offering cystic fibrosis therapeutic products worldwide include AbbVie, Gilead Sciences, Roche, Pharmaxis Ltd., Nestle Health Science, and Vertex Pharmaceutical Incorporated, among others.

Cystic Fibrosis Therapeutics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2020
  • Companies covered: 10
  • Tables & Figures: 96
  • Countries covered: 11
  • Pages: 100
 Download Free Sample